MiR‐15a/16 deficiency enhances anti‐tumor immunity of glioma‐infiltrating CD8+ T cells through targeting mTOR
Jiao Yang(Chinese Academy of Sciences), Yiwei Chu(Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Yuedi Wang(Fudan University), Dan Zhang(Fudan University), Ronghua Liu(Agriculture and Agri-Food Canada), Jiawen Qian(Fudan University), Zhou Lu(Fudan University), Yuting Deng(Shanghai Medical College of Fudan University)
Cited by 82
Related Papers
SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice
|Cell Reports|2017|340
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Evaluation of the Stability and Antioxidant Activity of Nanoencapsulated Resveratrol during in Vitro Digestion
|Journal of Agricultural and Food Chemistry|2011|192
Lipid metabolism in inflammation-related diseases
|The Analyst|2018|183
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183